A novel urinary biomarker predicts 1-year mortality after discharge from intensive care

Esther Nkuipou-Kenfack, Agnieszka Latosinska, Wen-Yi Yang, Marie-Celine Fournier, Alice Blet, Blerim Mujaj, Lutgarde Thijs, Elodie Feliot, Etienne Gayat, Harald Mischak, Jan A. Staessen, A. Mebazaa, Zhen-Yu Zhang*, N. Deye, C. Fauvaux, A. Mebazaa, C. Damoisel, D. Payen, E. Azoulay, A. S. MoreauL. Jacob, O. Marie, M. Wolf, R. Sonneville, R. Bronchard, I. Rennuit, C. Paugam, J. P. Mira, A. Cariou, A. Tesnieres, N. Dufour, N. Anguel, L. Guerin, J. Duranteau, C. Ract, M. Leone, B. Pastene, T. Sharshar, A. Fayssoyl, J. L. Baudel, B. Guidet, Q. Lu, W. Jie Gu, N. Brechot, A. Combes, S. Jaber, A. Pradel, Y. Coisel, M. Conseil, A. Vieillard-Baron, French European Outcome Registry

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number10
Number of pages11
JournalCritical Care
Volume24
Issue number1
DOIs
Publication statusPublished - 9 Jan 2020

Keywords

  • Biomarker
  • Intensive care medicine
  • Heart failure
  • Mortality
  • Urinary proteomics
  • GELATINASE-ASSOCIATED LIPOCALIN
  • BRAIN NATRIURETIC PEPTIDE
  • ACUTE KIDNEY INJURY
  • UNIT ADMISSION
  • TERMINAL PRO
  • SOLUBLE ST2
  • PROTEOME
  • DISEASE
  • DIAGNOSIS
  • NGAL

Cite this